246 related articles for article (PubMed ID: 15389473)
1. Contralateral prophylactic mastectomy. Predictors of significant histologic findings.
Goldflam K; Hunt KK; Gershenwald JE; Singletary SE; Mirza N; Kuerer HM; Babiera GV; Ames FC; Ross MI; Feig BW; Sahin AA; Arun B; Meric-Bernstam F
Cancer; 2004 Nov; 101(9):1977-86. PubMed ID: 15389473
[TBL] [Abstract][Full Text] [Related]
2. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
[TBL] [Abstract][Full Text] [Related]
3. Should the use of contralateral prophylactic mastectomy be increasing as it is?
Wood WC
Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
[TBL] [Abstract][Full Text] [Related]
4. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.
Soran A; Falk J; Bonaventura M; Keenan D; Ahrendt G; Johnson R
Ann Surg Oncol; 2007 Feb; 14(2):646-51. PubMed ID: 17122987
[TBL] [Abstract][Full Text] [Related]
5. Perceptions of contralateral breast cancer: an overestimation of risk.
Abbott A; Rueth N; Pappas-Varco S; Kuntz K; Kerr E; Tuttle T
Ann Surg Oncol; 2011 Oct; 18(11):3129-36. PubMed ID: 21947590
[TBL] [Abstract][Full Text] [Related]
6. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
Tuttle TM; Jarosek S; Habermann EB; Arrington A; Abraham A; Morris TJ; Virnig BA
J Clin Oncol; 2009 Mar; 27(9):1362-7. PubMed ID: 19224844
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
[TBL] [Abstract][Full Text] [Related]
8. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
9. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
[TBL] [Abstract][Full Text] [Related]
10. Contralateral prophylactic mastectomy.
Rai SS; Mahabir RC; Roberts JW; Song J; Hamid KS; White RR
Ann Plast Surg; 2011 Sep; 67(3):215-9. PubMed ID: 21508813
[TBL] [Abstract][Full Text] [Related]
11. Clinical and histological predictors of contralateral breast cancer.
Kollias J; Ellis IO; Elston CW; Blamey RW
Eur J Surg Oncol; 1999 Dec; 25(6):584-9. PubMed ID: 10556004
[TBL] [Abstract][Full Text] [Related]
12. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
Chuba PJ; Hamre MR; Yap J; Severson RK; Lucas D; Shamsa F; Aref A
J Clin Oncol; 2005 Aug; 23(24):5534-41. PubMed ID: 16110014
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.
Herrinton LJ; Barlow WE; Yu O; Geiger AM; Elmore JG; Barton MB; Harris EL; Rolnick S; Pardee R; Husson G; Macedo A; Fletcher SW
J Clin Oncol; 2005 Jul; 23(19):4275-86. PubMed ID: 15795415
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005.
McLaughlin CC; Lillquist PP; Edge SB
Cancer; 2009 Dec; 115(23):5404-12. PubMed ID: 19787635
[TBL] [Abstract][Full Text] [Related]
15. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.
Shahedi K; Emanuelsson M; Wiklund F; Gronberg H
Cancer; 2006 Mar; 106(6):1237-42. PubMed ID: 16475207
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
Hartmann LC; Schaid DJ; Woods JE; Crotty TP; Myers JL; Arnold PG; Petty PM; Sellers TA; Johnson JL; McDonnell SK; Frost MH; Jenkins RB
N Engl J Med; 1999 Jan; 340(2):77-84. PubMed ID: 9887158
[TBL] [Abstract][Full Text] [Related]
17. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
18. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution.
Jones NB; Wilson J; Kotur L; Stephens J; Farrar WB; Agnese DM
Ann Surg Oncol; 2009 Oct; 16(10):2691-6. PubMed ID: 19506956
[TBL] [Abstract][Full Text] [Related]
19. Stratification of breast cancer risk in women with atypia: a Mayo cohort study.
Degnim AC; Visscher DW; Berman HK; Frost MH; Sellers TA; Vierkant RA; Maloney SD; Pankratz VS; de Groen PC; Lingle WL; Ghosh K; Penheiter L; Tlsty T; Melton LJ; Reynolds CA; Hartmann LC
J Clin Oncol; 2007 Jul; 25(19):2671-7. PubMed ID: 17563394
[TBL] [Abstract][Full Text] [Related]
20. Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer.
Isern AE; Loman N; Malina J; Olsson H; Ringberg A
Eur J Surg Oncol; 2008 Oct; 34(10):1148-54. PubMed ID: 18434071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
